Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

被引：4
|
作者：
Meibohm, Bernd [1 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA
来源：
CLINICAL PHARMACOKINETICS | 2011年 / 50卷 / 12期
关键词：
MODEL;
D O I：
10.2165/11597950-000000000-00000
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [41] Therapeutic drug monitoring of monoclonal antibodies: Applicability based on their pharmacokinetic properties
    Imamura, Chiyo K.
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : 14 - 18
  • [42] Pharmacokinetic Modeling and Predictive Performance: Practical Considerations for Therapeutic Monoclonal Antibodies
    Chen, Yang
    Li, Joshua
    Li, Derry
    Hu, Chuanpu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (05) : 595 - 600
  • [43] Pharmacokinetic Modeling and Predictive Performance: Practical Considerations for Therapeutic Monoclonal Antibodies
    Yang Chen
    Joshua Li
    Derry Li
    Chuanpu Hu
    European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 595 - 600
  • [44] Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies
    Reig-Lopez, Javier
    Tang, Weifeng
    Fernandez-Teruel, Carlos
    Merino-Sanjuan, Matilde
    Mangas-Sanjuan, Victor
    Boulton, David W.
    Sharma, Pradeep
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (09) : 2691 - 2702
  • [45] Lipid effects of torcetrapib with and without atorvastatin are optimized by morning dosing: Results from pharmacokinetic/pharmacodynamic analyses
    Gibbs, M
    Riggs, M
    Russell, T
    Wei, G
    Digenio, A
    Thuren, T
    Shear, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 349A - 349A
  • [46] RATIONAL WARFARIN DOSING - A PHARMACOKINETIC-PHARMACODYNAMIC ANALYSIS
    HOLFORD, NHG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 199 - 199
  • [47] PERMANENT PDA CLOSURE WITH PHARMACOKINETIC PHARMACODYNAMIC DOSING OF INDOMETHACIN
    GAL, P
    SCHALL, S
    RANSOM, JL
    WEAVER, RL
    WYBLE, LE
    CARLOS, RQ
    BROWN, Y
    PEDIATRIC RESEARCH, 1991, 29 (04) : A243 - A243
  • [48] The importance of appropriate antimicrobial dosing: Pharmacokinetic and pharmacodynamic considerations
    Preston, SL
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : S14 - S18
  • [49] Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
    Onufrak, Nikolas J.
    Forrest, Alan
    Gonzalez, Daniel
    CLINICAL THERAPEUTICS, 2016, 38 (09) : 1930 - 1947
  • [50] Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis
    Sherwin, Catherine M. T.
    Svahn, Sofia
    Van Der Linden, Antje
    Broadbent, Roland S.
    Medlicott, Natalie J.
    Reith, David M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (07) : 705 - 713
12345